Published in Pharma Investments, Ventures and Law Weekly, August 28th, 2005
In addition, Adams has granted to the underwriters a 30-day over-allotment option to purchase up to an additional 1,192,000 shares. The Adams common stock is expected to begin trading on the Nasdaq National Market on July 21, 2005, under the symbol "ARXT."
The proceeds to Adams from the offering are expected to be approximately $87.7...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly